Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis
PLOS One · 2026
DOI: 10.1371/journal.pone.0359405 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Zihui Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, P.R. China. Hauptthemen laut MEDLINE: Signal Transduction, Esophageal Neoplasms, Drugs, Chinese Herbal, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, Hebei Province Graduate Innovation Funding Project.
Abstract (Originalsprache)
Shenling Qige Granules (SLQG), derived from the Qing Dynasty formula Qige San recorded in Yi Xue Xin Wu , has been used in clinical practice in China as an adjuvant traditional Chinese medicine preparation for esophageal squamous cell carcinoma (ESCC), but its molecular basis remains unclear. This study investigated the antitumor effects and mechanisms of SLQG using TE-1 xenograft mice and SLQG-containing serum-treated TE-1 cells. Transcriptome sequencing, network pharmacology, molecular docking, molecular dynamics simulation, and public-database analysis were integrated to prioritize candidate mechanisms. Histological, molecular, cellular, and siRNA-mediated decorin ( DCN ) knockdown assays were performed for validation. SLQG, especially at the medium dose, inhibited xenograft tumor growth and increased DCN expression. Transcriptomic analysis highlighted the transforming growth factor-β (TGF-β)/Smad pathway. In silico analyses suggested that several SLQG-derived compounds, particularly ursolic acid, may be associated with DCN-related regulation. Public-database analysis indicated lower DCN expression in esophageal carcinoma tumor samples than in normal samples and an association with pathological stage. In vivo and in vitro, SLQG increased DCN expression, reduced Smad2/3 phosphorylation, promoted pro-apoptotic signaling, and induced G 0 /G 1 arrest; these effects were attenuated by DCN knockdown. These findings suggest that SLQG inhibited ESCC progression in TE-1 xenograft and cell-based models, potentially through modulation of the DCN-associated TGF-β/Smad signaling axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, P.R. China.
- Second Department of Oncology, The First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Hebei, P.R. China.
- Department of Pediatric Rehabilitation, The First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Hebei, P.R. China.
ORCID-Profile: Zihui Liu, Huanfang Fan
Förderung
- Natural Science Foundation of Hebei Province
- Hebei Province Graduate Innovation Funding Project
Zitieren
APA
Liu, Z., Gu, Y., Fan, H., Huang, M., Li, D., Guo, W., He, Y., Zhang, S., & Du, Z. (2026). Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis. PLOS One. https://doi.org/10.1371/journal.pone.0359405
Vancouver
Liu Z, Gu Y, Fan H, Huang M, Li D, Guo W, et al. Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis. PLOS One. 2026. doi:10.1371/journal.pone.0359405
BibTeX
@article{Liu2026,
author = {Liu, Zihui and Gu, Yiting and Fan, Huanfang and Huang, Mao and Li, Dehui and Guo, Wen and He, Yun and Zhang, Shuang and Du, Zhihua},
title = {Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0359405}
}
EUVIMED